Endeavor BioMedicines is a private drug discovery company. It has raised $133 million across 2 recorded rounds; the latest was a $133 million Series C in Apr 2024.
PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$132.5M
Last round
Later Stage VC (Series C)
Apr 2024
Investors — not yet on record
No investors in Endeavor BioMedicines are on record yet. Backers surface from round announcements, filings, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Endeavor BioMedicines with a free account
·Watch Endeavor BioMedicines: the Monday email on marks, rounds and moves
